Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.39 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6313359 | 0.98 | CYP3A4 (0.62) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL6312852 | 0.98 | CYP3A4 (0.62) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL852624 | 0.97 | CYP3A4 (0.60) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL9353575 | 0.95 | CYP3A4 (0.58) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| Pyrophosphoric Acid SCHEMBL27789794 | 0.93 | CYP3A4 (0.64) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL1123667 | 0.93 | CYP3A4 (0.68) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL27678596 | 0.90 | CYP3A4 (0.72) | CYP3A4L3MBTL1TSHRATMTDP1 | |
| SCHEMBL116247 | 0.90 | CYP3A4 (0.72) | CYP3A4L3MBTL1TSHRATMTDP1 | |
| SCHEMBL4179890 | 0.89 | CYP3A4 (0.68) | CYP3A4L3MBTL1LPAR3LPAR1TSHR | |
| SCHEMBL28843726 | 0.88 | CYP3A4 (0.66) | CYP3A4L3MBTL1LPAR3LPAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5378736-A | Epoxidized polylactone, coatings | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-03 | — | — | US | claimed |
| EP-0466596-B1 | Lactone-modified alicyclic composition, and an epoxidized composition thereof | DAICEL CHEM (JP) | 1994-10-05 | — | — | EP | claimed |
| EP-0459913-B1 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEM (JP) | 1994-07-27 | — | — | EP | claimed |
| EP-0466596-A2 | Lactone-modified alicyclic composition, and an epoxidized composition thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-01-15 | — | — | EP | claimed |
| EP-0459913-A2 | Composition comprising a novel alicyclic compound, a process for the preparation thereof, a curable composition, and a photo-polymerizable composition | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-12-04 | — | — | EP | claimed |
| JP-2188576-A | — | — | None | — | — | JP | disclosed |
| US-11932723-B2 | High-purity 3,4-epoxycyclohexylmethyl methacrylate | DAICEL CORPORATION (JP) | 2024-03-19 | — | — | US | disclosed |
| CN-115058004-B | Easily-soluble reactive permanent antistatic agent and preparation method thereof | 汤臣(江苏)材料科技股份有限公司 | 2023-06-09 | — | — | CN | disclosed |
| CN-115058004-A | Easily-soluble reactive permanent antistatic agent and preparation method thereof | 汤臣(江苏)材料科技股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| US-20220089808-A1 | HIGH-PURITY 3,4-EPOXYCYCLOHEXYLMETHYL METHACRYLATE | DAICEL CORPORATION (JP) | 2022-03-24 | — | — | US | disclosed |
| CN-113227062-A | High purity 3, 4-epoxycyclohexylmethyl methacrylate | 株式会社大赛璐 | 2021-08-06 | — | — | CN | disclosed |
| CN-112313186-A | Additive for hydraulic composition | 竹本油脂株式会社 | 2021-02-02 | — | — | CN | disclosed |
| EP-0437342-A2 | Method for handling maleimides | NIPPON SHOKUBAI CO., LTD. (JP) | 1991-07-17 | — | — | EP | disclosed |
| JP-H02188576-A | EPOXIDIZED (METH)ACRYLATE COMPOSITION | DAICEL CHEM IND LTD | 1990-07-24 | — | — | JP | disclosed |
| EP-0068326-B1 | BIS-PHENOL PHOSPHATES AS CLARIFIERS FOR POLYOLEFIN RESINS | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1986-02-19 | — | — | EP | disclosed |
| US-4463113-A | Bis-phenol phosphates as clarifiers for polyolefin resins | ADEKA ARGUS CHEMICAL CO., LTD. URAWA, JAPAN A CORP OF (JP) | 1984-07-31 | — | — | US | disclosed |
| EP-0068326-A2 | Bis-phenol phosphates as clarifiers for polyolefin resins | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1983-01-05 | — | — | EP | disclosed |
| US-4334999-A | FROM WATER INSOLUBLE COMPOUND DISPERSED IN AQUEOUS SOLUTION BY ION EXCHANGE WITH ALKYL ACID PHOSPHATE AND SOLVENT EXTRACTION | BOARD OF TRUSTEES, MICHIGAN STATE UNIVERSITY (US) | 1982-06-15 | — | — | US | disclosed |
| US-4292284-A | USING AN IMMISCIBLE SOLVENT WITH AN AQUEOUS MIXTURE OF A MONOALKYL AND/OR A DIALKYL AND A TRIALKYL PHOSPHATE | TOHO AEN KABUSHIKI KAISHA (JP) | 1981-09-29 | — | — | US | disclosed |
| US-4258142-A | ADDING A PHENYL PHOSPHATE AND METAL COMPOUND | ARGUS CHEMICAL CORP. (US) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089808-A1 | HIGH-PURITY 3,4-EPOXYCYCLOHEXYLMETHYL METHACRYLATE | MEP1A, MEP1B, FTO | CYP3A4 717/4885L3MBTL1 1391/4885LPAR3 3987/4885 |
| US-11932723-B2 | High-purity 3,4-epoxycyclohexylmethyl methacrylate | MEP1A, MEP1B, FTO | CYP3A4 717/4885L3MBTL1 1391/4885LPAR3 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.